BPC-157s effects on multiple neurotransmitter systems create theoretical interaction points with psychiatric medications, yet interactions are not well studied. Particular concerns include serotonin syndrome risk when combined with SSRIs (since BPC-157 modulates serotonin in complex regional patterns), unpredictable effects on dopaminergic medications (antipsychotics, ADHD treatments, Parkinsons medications), and unknown interactions with benzodiazepines despite the animal studies showing tolerance prevention
Effective management includes moisturizing, avoiding irritants, and sometimes prescription treatments
Known for its ability to promote healing, collagen production and tissue repair, the copper-binding peptide is supported by scientific research
Derry PJ, Hegde ML, Jackson GR, Kayed R, Tour JM, Tsai AL, et al